Cargando…

The Short-Term Effect of Eugenol on the Prevention of Experimentally Induced Myringosclerosis in a Rat Model

OBJECTIVE: The aim of our study was to assess the possible short-term effects of topical and oral eugenol on the suppression of experimentally developed myringosclerosis (MS). METHODS: Four groups of seven male Wistar albino rats were used in the study. The tympanic membranes (TMs) of all subjects w...

Descripción completa

Detalles Bibliográficos
Autores principales: Eğilmez, Oğuz Kadir, Güven, Mehmet, Genç Elden, Sena, Budak, Özcan, Çakıroğlu, Hüseyin, Elden, Halil, Güven, Ebru Mihriban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329402/
https://www.ncbi.nlm.nih.gov/pubmed/34386799
http://dx.doi.org/10.4274/tao.2021.6196
Descripción
Sumario:OBJECTIVE: The aim of our study was to assess the possible short-term effects of topical and oral eugenol on the suppression of experimentally developed myringosclerosis (MS). METHODS: Four groups of seven male Wistar albino rats were used in the study. The tympanic membranes (TMs) of all subjects were myringotomized, and group 1 was given no treatment (as control group), group 2 received saline, group 3 had received topical eugenol and group 4 received oral eugenol. RESULTS: In macroscopic evaluation the control and saline groups showed much more MS compared to the topical and oral eugenol groups which had statistically significantly less changes (p<0.05). Fibrosis and inflammation regarding the lamina propria (LP) of the eardrums of the topical and oral eugenol groups were significantly less than those of the control and saline groups (p<0.001). In microscopic evaluation, TMs were found to be thicker in the control and saline groups (p<0.001). CONCLUSION: Our study showed that the application of topical and oral forms of eugenol reduced fibrosis and prevented the advancement of MS in the LP of the TMs in the short-term. More studies with different extracts are needed to investigate the efficacy of phytotherapeutic agents for preventing MS development following myringotomy.